Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s12879-021-06108-5 http://scihub22266oqcxt.onion/10.1186/s12879-021-06108-5 33947347!8093594!33947347     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       BMC+Infect+Dis 2021 ; 21 (1): 410 Nephropedia Template TP {{tp|p=33947347|t=2021. Salivary testing of COVID-19: evaluation of serological testing following positive salivary results |pdf=|usr=}}{{33947347}} gab.com Text Salivary testing of COVID-19: evaluation of serological testing following positive salivary results JO: BMC Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=33947347 #FOAvip BACKGROUND: Salivary detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been proposed as an alternative to nasopharyngeal or oropharyngeal swab testing. Our group previously published a study demonstrating that both testing methods identified SARS-CoV-2 using polymerase chain reaction (PCR)-based detection methodology. We therefore conducted a follow-up study using antibody testing to evaluate the accuracy of saliva versus swabs for COVID-19 detection and the durability of antibody response. METHODS: Venous blood samples were collected from consenting participants and the presence of serum antibodies for SARS-CoV-2 was evaluated on a large, automated immunoassay platform by the Roche anti-SARS-CoV-2 qualitative assay (Roche Diagnostics, Laval Quebec). Individuals with a serum antibody cut-off index (COI) >/= 1.0 were considered positive. RESULTS: In asymptomatic and mildly symptomatic patients with a previously positive standard swab and/or saliva SARS-CoV-2 PCR-test, 42 demonstrated antibodies with 13 patients positive by swab alone, and 8 patients positive by saliva alone. CONCLUSIONS: Despite their status as 'current standard' for COVID-19 testing, these findings highlight limitations of PCR-based tests. Twit Text FOAVip Salivary testing of COVID-19: evaluation of serological testing following positive salivary results ????BMC Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=33947347 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33947347 #FOAvip English Wikipedia <ref>{{Cite pmid|33947347}}</ref> Salivary testing of COVID-19: evaluation of serological testing following positive salivary results #MMPMID33947347 Caulley L; Shaw J; Corsten M; Hua N; Angel JB; Poliquin G; Whelan J; Antonation K; Johnson-Obaseki S BMC Infect Dis 2021[May]; 21 (1): 410 PMID33947347show ga BACKGROUND: Salivary detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been proposed as an alternative to nasopharyngeal or oropharyngeal swab testing. Our group previously published a study demonstrating that both testing methods identified SARS-CoV-2 using polymerase chain reaction (PCR)-based detection methodology. We therefore conducted a follow-up study using antibody testing to evaluate the accuracy of saliva versus swabs for COVID-19 detection and the durability of antibody response. METHODS: Venous blood samples were collected from consenting participants and the presence of serum antibodies for SARS-CoV-2 was evaluated on a large, automated immunoassay platform by the Roche anti-SARS-CoV-2 qualitative assay (Roche Diagnostics, Laval Quebec). Individuals with a serum antibody cut-off index (COI) >/= 1.0 were considered positive. RESULTS: In asymptomatic and mildly symptomatic patients with a previously positive standard swab and/or saliva SARS-CoV-2 PCR-test, 42 demonstrated antibodies with 13 patients positive by swab alone, and 8 patients positive by saliva alone. CONCLUSIONS: Despite their status as 'current standard' for COVID-19 testing, these findings highlight limitations of PCR-based tests. |Adult[MESH] |Aged[MESH] |Antibodies, Viral/analysis/blood[MESH] |COVID-19 Nucleic Acid Testing/methods[MESH] |COVID-19 Serological Testing/*methods[MESH] |COVID-19/*immunology[MESH] |Female[MESH] |Follow-Up Studies[MESH] |Humans[MESH] |Immunity, Humoral[MESH] |Male[MESH] |Middle Aged[MESH] |Nasopharynx/virology[MESH] |Polymerase Chain Reaction[MESH] |SARS-CoV-2/genetics/immunology[MESH] |Saliva/*virology[MESH]Salivary testing of COVID-19: evaluation of serological testing follow(epmc).pdf DeepDyve Pubget Overpricing